ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Potential of metabolomics in preclinical and clinical drug development

Kumar, Baldeep; Prakash, Ajay; Ruhela, Rakesh Kumar; Medhi, Bikash*河北医科大学
Pharmacological Reports2014-12DOI: 10.1016/j.pharep.2014.06.010
29被引1阅读
引用收藏
分享

摘要

Metabolomics is an upcoming technology system which involves detailed experimental analysis of metabolic profiles. Due to its diverse applications in preclinical and clinical research, it became an useful tool for the drug discovery and drug development process. This review covers the brief outline about the instrumentation and interpretation of metabolic profiles. The applications of metabolomics have a considerable scope in the pharmaceutical industry, almost at each step from drug discovery to clinical development. These include finding drug target, potential safety and efficacy biomarkers and mechanisms of drug action, the validation of preclinical experimental models against human disease profiles, and the discovery of clinical safety and efficacy biomarkers. As we all know, nowadays the drug discovery and development process is a very expensive, and risky business. Failures at any stage of drug discovery and development process cost millions of dollars to the companies. Some of these failures or the associated risks could be prevented or minimized if there were better ways of drug screening, drug toxicity profiling and monitoring adverse drug reactions. Metabolomics potentially offers an effective route to address all the issues associated with the drug discovery and development.

学科与关键词

关键词
DrugMetabolomicsMetabolismToxicologyPharmacology
相关
加载中…
  • NMR Based etabolomics: An Exquisite and Facile Method for Evaluated Therapeutic Efficacy and Screening Drug Toxicity
    Guleria, Anupam*; Kumar, Amit; Kumar, Umesh; Raj, Ritu; Kumar, Dinesh*CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18(20): 1827-1849.被引 20
  • Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future
    Rankin, Naomi J.*; Preiss, David; Welsh, Paul; Sattar, NaveedInternational Journal of Epidemiology, 2016, 45(5): 1351-1371.被引 18
  • Metabolomics toward personalized medicine
    Jacob, Minnie; Lopata, Andreas L.; Dasouki, Majed; Rahman, Anas M. Abdel*Mass Spectrometry Reviews, 2019, 38(3): 221-238.被引 236
查看全部 →

发表信息

论文状态
公开发表
期刊
Pharmacological Reports
发表日期
2014-12
卷期
第 66 卷, 第 6 期
页码
956-963
DOI
10.1016/j.pharep.2014.06.010
语言
ENGLISH
期刊收录
SCIE
期刊等级
Q3
成果收录
SCIE

作者

  • K

    Kumar, Baldeep (第一作者)

    inst med

  • P

    Prakash, Ajay

    inst med

查看全部 4 位作者收起作者
  • R

    Ruhela, Rakesh Kumar

    inst med

  • M

    Medhi, Bikash (通讯)

    inst med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417